In multiple clinical studies, the GLP-1 agonist liraglutide has been shown to be an effective drug for Type 2 diabetes that can yield a good glycemic control and improve liver-enzyme levels [120]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.